Henry Mead

Henry Mead, PhD, currently serves as Senior Director of Medical Affairs for Hemophilia at BioMarin Pharmaceutical Inc. since July 2021. Prior to this role, Henry Mead held various positions at CSL Behring, including Director of Medical Communication & Education Strategy for Hematology and Director of Medical Therapeutic Area Leader for Coagulation. Additional experience includes Deputy Director of Global Medical Affairs at Bayer HealthCare and Associate Director of Global Scientific Affairs at Pfizer/Wyeth. Henry Mead began a career at Wyeth Canada as a Medical Science Liaison covering transplantation, hemophilia, and oncology. Academic qualifications include a PhD in Public Health Epidemiology from Walden University, an MPA in Public Health and an MBA in Management Sciences and Quantitative Methods from City University, and a B.Sc. in Biochemistry from The University of British Columbia.